Association of dual SGLT-2 inhibitor and GLP-1 receptor agonist therapy with colon cancer risk in post-polypectomy patients with diabetes: a target trial emulation. - Wang CH; Chang WC; Chen HY; Chen PH; Lin MH; Lee CH (Diabetology & metabolic syndrome, 2026)